Brought to you by 
Haemonetics, VI Technologies collaborate on Inactine
23 Apr 2015
Executive Summary
Haemonetics (automated blood processing systems) and VI Technologies (virally inactive blood products) will together develop components of a red cell viral inactivation system based on the use and removal of VI Technologies' Inactine.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Haemonetics, VI Technologies collaborate on Inactine
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice